News | June 03, 2022
CMP Pharma announces calcium channel blocker ‘Norliqva’ availability
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company
The site, located in Berkeley County, will be operated using the same quality standards as DuPont’s Healthcare Industries Materials Site, the company’s longstanding biopharmaceutical manufacturing site in Hemlock, Michigan
By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry.
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Subscribe To Our Newsletter & Stay Updated
